Sanofi's Rilzabrutinib gets orphan designation by FDA for AIHA treatment
Go back to Sanofi's Rilzabrutinib gets orphan designation by FDA for AIHA treatment| SANOFI (NASDAQ: SNY) | Delayed: 42.52 -0.2 (0.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $42.72 | 52 Week High | $44.76 | |||
| Open | $42.81 | 52 Week Low | $36.81 | |||
| Day High | $42.89 | P/E | N/A | |||
| Day Low | $42.41 | EPS | $0.00 | |||
| Volume | 941,230 | |||||
